UNCOVERED: Is abbott stock underperforming the s p 500 - The Untold Story

Abbott Laboratories (ABT), with a market cap of $197.1 billion, is a North Chicago-based company that delivers innovative medical devices and healthcare solutions. It operates across four key segments: Established Pharmaceuticals, Diagnostics, Nutrition, and Medical Devices.

Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Abbott fits this criterion perfectly, exceeding the mark. Its strengths lie in its global presence, operating in over 160 countries with 60% of sales outside the U.S., and its diverse product portfolio, which includes medical devices and nutritional products, ensuring multiple revenue streams and reduced risk.